NHS waiting lists 2026 remain one of the biggest operational challenges facing healthcare services in England. Although recent figures show encouraging progress, millions of pathways remain on the elective waiting list, meaning reducing waiting times continues to be a major priority for NHS trusts, integrated care boards (ICBs), clinical teams and the Government.
The situation is not simply about performing more operations. Reducing waiting times requires changes across the whole patient pathway: referrals, outpatient appointments, diagnostic tests, theatre capacity, community services, technology, workforce productivity and the way patients are directed to appropriate services.
There are now signs that these measures are having an impact. NHS England reported that the elective waiting list had fallen to 7.11 million pathways by March 2026, its lowest level for three and a half years. In the same month, 65.3% of patients were waiting no more than 18 weeks, meeting the national target set for March 2026. The overall waiting list was also more than half a million lower than its July 2024 level.
However, this does not mean the challenge has been solved. The longer-term ambition is much more demanding: restoring the NHS constitutional standard so that at least 92% of patients wait no more than 18 weeks for treatment by the end of 2028/29.
So, what is actually being done to get there?
What Do NHS Waiting Lists Actually Measure?
When people talk about the NHS waiting list, they are generally referring to referral-to-treatment, or RTT, pathways for planned consultant-led care.
Elective care covers a broad range of planned, non-emergency healthcare, including outpatient appointments, diagnostic investigations, operations and other treatments.
Importantly, the headline waiting-list figure represents pathways rather than necessarily individual people. A patient may therefore appear on more than one pathway if they are awaiting treatment for different conditions.
The NHS constitutional standard is that at least 92% of patients should wait no longer than 18 weeks from referral to the start of consultant-led treatment. The NHS is working towards restoring this standard by March 2029.
Are NHS Waiting Lists Going Down in 2026?
There has been measurable progress.
NHS England reported in May 2026 that the overall waiting list had fallen to 7.11 million pathways in March, the lowest level for three and a half years. It was down by 515,000 from July 2024.
At the same time, 65.3% of patients were waiting no more than 18 weeks, while around 450,000 fewer people were waiting beyond 18 weeks compared with July 2024.
NHS England also reported that more than 18.6 million patients had started treatment or completed their care during the previous 12 months, over half a million more than the previous year.
These figures show that the direction of travel has improved. But getting from approximately two-thirds of pathways within 18 weeks to the constitutional standard of 92% requires sustained change rather than a short-term increase in activity.
For 2026/27, NHS England expects the national waiting list to reduce, with reductions expected across all trusts. The national target is for 70% of patients to be waiting no more than 18 weeks by the end of the financial year. Each trust is expected to achieve at least a seven percentage-point improvement in 18-week performance or reach at least 65%, whichever represents the applicable requirement.
NHS Waiting Lists 2026: What Is Being Done to Reduce Them?
There is no single solution to the backlog. NHS England’s approach combines additional activity with significant reform to where, when and how planned care is delivered.
The most obvious requirement is increasing the amount of planned care that the NHS can deliver.
This includes consultations, diagnostic investigations, procedures and operations. But increasing activity is not simply a case of asking existing hospitals to work harder.
Capacity depends on available staff, theatre space, diagnostics, beds, equipment, consumables and the flow of patients through different parts of the system.
This is why productivity is increasingly important alongside headline activity numbers. If clinical teams lose time because essential equipment is unavailable, patients are moved unnecessarily between locations, appointments are duplicated or pathways contain avoidable administrative steps, capacity that could otherwise be used for patient care is lost.
One important part of elective recovery has been the development and use of surgical hubs.
By creating dedicated capacity for planned procedures, healthcare systems can separate some elective activity from the unpredictable pressures associated with emergency admissions.
NHS England’s elective reform programme specifically identifies capacity upgrades including surgical hubs as part of efforts to improve elective services.
This matters because elective operating lists can be disrupted when emergency demand competes for staff, beds or theatre capacity.
More protected elective capacity can therefore help NHS organisations deliver planned procedures more consistently.
Diagnostics are another crucial part of the waiting-list challenge.
A patient cannot move efficiently through a pathway if they are waiting weeks for a scan, test or investigation needed to confirm a diagnosis or determine treatment.
The NHS Medium Term Planning Framework aims for no more than 14% of patients to be waiting over six weeks for a diagnostic test by the end of 2026/27, before ultimately returning to the standard of no more than 1% by the end of 2028/29.
Community Diagnostic Centres and other models that provide tests outside traditional acute hospital settings can help create additional diagnostic capacity and make services more accessible.
The principle is important: reducing the treatment backlog also requires reducing the bottlenecks that occur before treatment.
One of the biggest strategic changes taking place across the NHS is the movement from hospital-based care towards community and neighbourhood services.
This has implications for waiting lists.
If suitable patients can be assessed, monitored, rehabilitated or supported closer to home, hospital resources can be focused on patients who genuinely require specialist acute care.
NHS England states that timely access to community health services can reduce pressure on both elective and urgent and emergency care. For 2026/27, the objective is for at least 78% of community health service activity to occur within 18 weeks, increasing to at least 80% by the end of 2028/29.
This shift also creates practical requirements around medical equipment, point-of-care testing, digital connectivity and suitable clinical supplies outside traditional hospital environments.
Another important question is whether every traditional hospital follow-up appointment is necessary.
NHS England’s current planning framework asks providers and commissioners to identify opportunities to reduce unnecessary outpatient follow-up activity through approaches including patient-initiated follow-up, remote consultations and digital monitoring.
The aim is not simply to remove appointments. Follow-up arrangements still need to be clinically appropriate.
Instead, the principle is to use clinical capacity more intelligently. If an appropriate patient can contact a service when they need follow-up rather than automatically returning at a fixed interval, that capacity may be available for another patient who needs assessment or treatment.
At scale, these changes can make a meaningful contribution to elective capacity.
The Growing Role of Technology and AI
Digital technology is increasingly becoming part of the waiting-list strategy.
In July 2026, NHS England announced an accelerated rollout of artificial intelligence tools, including an AI triage tool within the NHS App designed to help direct patients towards the most appropriate service. The tool is expected to reach more than 200,000 patients within 12 months, with wider availability planned by April 2028.
AI-supported notetaking is also being expanded with the aim of reducing administrative workload for NHS staff.
Technology will not replace the need for clinical capacity, but it may help reduce avoidable administration, improve communication and direct patients more efficiently.
The NHS App is also becoming increasingly important for communication with patients waiting for care. Better digital communication may help reduce missed appointments and give patients greater visibility and control over their treatment pathway.
Giving Patients More Choice
Patient choice is another part of elective reform.
Where clinically appropriate, patients may be able to access treatment from a different provider if this means receiving care sooner.
The NHS elective reform programme specifically identifies giving patients greater choice and control over when and where they receive treatment as part of the strategy for restoring the 18-week standard.
This changes the waiting-list challenge from being entirely organisation-specific towards a broader capacity question: where within the healthcare system can the patient receive appropriate treatment most efficiently?
Improving Waiting-List Data
There is also a less visible part of the work: ensuring waiting lists accurately reflect who is still waiting and what they are waiting for.
For 2026/27, providers and ICBs are expected to actively manage their waiting lists through validation, accurate application of referral-to-treatment guidance and improved data quality.
NHS England also expects providers to use the Federated Data Platform or equivalent technology to support these improvements.
Accurate data matters because healthcare organisations cannot effectively plan theatre capacity, diagnostics, workforce requirements or clinical resources if they do not have a reliable picture of demand.
What Does Reducing Waiting Lists Mean for NHS Procurement?
Waiting-list recovery is often discussed as a clinical and workforce issue, but there is an important procurement dimension.
Additional activity requires additional capacity, and capacity depends partly on having the correct products, equipment and consumables available at the correct location and time.
Procurement teams therefore have to consider more than the purchase price of an individual product.
Supply continuity, lead times, product suitability, standardisation, availability, staff requirements and the operational consequences of a supply interruption can all affect healthcare delivery.
For example, increasing theatre activity may increase demand for surgical consumables, patient positioning equipment and associated clinical supplies. Expanding diagnostic capacity can create requirements for diagnostic and laboratory consumables. Moving services into community settings may require equipment that can be deployed outside traditional acute hospitals.
Procurement cannot solve waiting lists by itself. However, effective procurement can help clinical teams avoid unnecessary operational barriers while services increase capacity.
Where Niche Healthcare Fits In
Niche Healthcare supports NHS trusts, hospitals, community healthcare services and specialist clinical teams with healthcare equipment, medical products and procurement solutions.
Our healthcare portfolio includes areas such as neonatal and maternity care, patient warming, emergency response, infection prevention, clinical consumables, medical devices, ward and theatre equipment and specialist healthcare products.
As healthcare pathways continue to change, procurement requirements are changing with them. Increasing elective activity, developing community services and creating new models of planned care can require organisations to source products for different clinical environments and applications.
Niche Healthcare works with healthcare professionals and procurement teams to help source both established products and more specialist requirements, with the aim of making healthcare procurement more straightforward.
What Happens Next?
The NHS waiting-list strategy extends beyond 2026.
The Medium Term Planning Framework sets a target for 70% of patients to be waiting no more than 18 weeks during 2026/27, before ultimately restoring the constitutional standard of at least 92% by the end of 2028/29.
The same programme includes ambitious improvements in diagnostic waiting times, community services and cancer pathways.
The challenge is therefore shifting from short-term backlog recovery towards redesigning how planned healthcare is delivered.
That means asking not only “How can we treat more patients?” but also “How can the pathway itself work better?”
Frequently Asked Questions
How large is the NHS waiting list in 2026?
NHS England reported that the elective waiting list stood at 7.11 million pathways in March 2026, its lowest level for three and a half years at that point and 515,000 lower than in July 2024.
What is the NHS 18-week target?
The constitutional standard is for at least 92% of patients to wait no more than 18 weeks from referral to the start of consultant-led treatment. NHS England aims to restore this standard by the end of 2028/29.
How is the NHS reducing waiting lists?
The strategy includes increasing elective activity, expanding and optimising surgical hubs and diagnostic capacity, delivering more care in community settings, reducing unnecessary outpatient follow-ups, improving patient choice, using digital technology and AI, improving waiting-list data and increasing productivity.
Are NHS waiting lists actually falling?
Yes. NHS England reported in May 2026 that the waiting list had fallen by more than half a million pathways from July 2024 to March 2026. However, millions of pathways remain on the waiting list and the NHS still has substantial progress to make before restoring the 92% 18-week standard.
What is the NHS waiting-list target for 2026/27?
The national target is for 70% of patients to be waiting no more than 18 weeks for treatment by the end of 2026/27, alongside an expectation that the overall waiting list will reduce during the year.
Why are diagnostic waiting times important?
Diagnosis is often an essential step before a treatment decision can be made. Delays in imaging, testing or other investigations can therefore delay the entire patient pathway. NHS England aims to reduce the proportion of diagnostic referrals waiting more than six weeks to no more than 14% nationally during 2026/27, before returning to the 1% standard by the end of 2028/29.
Conclusion: NHS Waiting Lists 2026 and the Road Ahead
NHS waiting lists 2026 remain a major challenge, but the latest evidence shows that progress is possible. The waiting list has fallen from its previous peak, 18-week performance has improved and the NHS is now working towards further reductions during 2026/27.
The next stage will require more than simply increasing the number of appointments and operations.
Surgical hubs, diagnostic capacity, community healthcare, digital technology, AI, better patient communication, improved data and more productive outpatient pathways all form part of a broader transformation in how elective care is delivered.
For NHS trusts, clinical teams and procurement professionals, that transformation also reinforces the importance of ensuring services have access to suitable equipment, consumables and healthcare supplies as capacity expands and care moves into new settings.
Niche Healthcare will continue supporting healthcare organisations with medical equipment, specialist healthcare products and procurement solutions designed around the practical requirements of modern healthcare delivery.
Authoritative Further Reading
NHS England – Medium Term Planning Framework 2026/27 to 2028/29
NHS England – Reforming Elective Care for Patients
NHS England – Minimum Standards for Planned Patient Care
Published by Maisie McNamara | Clinical Marketing Team
NHS Waiting Lists Blog Infographic
3 Tier Trolley for Healthcare, Office & Workplace Storage
See our full selection:
Healthcare Supplies in Aberdeen | Niche Healthcare
Healthcare Supplies in Basildon | Niche Healthcare
Healthcare Supplies in Basingstoke | Niche Healthcare
Healthcare Supplies in London | Niche Healthcare
For procurement details, bulk purchasing, and further product information, contact our team today on 01274 965089 or check out our website at www.nicheofficesolutions.co.uk / www.nicheofficesolutions.co.uk/niche-nhs
Further clinical information can be found on our blog page: www.nicheofficesolutions.co.uk/category/niche-healthcare-news
For products not found on our online website, please view our Healthcare catalogues: www.nicheofficesolutions.co.uk/healthcare-catalogues
View our Healthcare YouTube videos Playlist
If you have any additional questions, drop us an email at info@nicheofficesolutions.co.uk